Skip to content
2000
Volume 6, Issue 4
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

COVID-19, caused by the SARS-CoV-2 virus, has emerged as a global threat. The journey of COVID-19, from its origins in Wuhan in 2019 to the emergence of various variants, including the recent JN.1 subvariant, is a complex narrative marked by global efforts to control the pandemic. The progression of the virus in India, as illustrated by data from 2020 to 2023, reflects both the challenges faced and the resilience exhibited by different states. The decline in cases in 2023, compared to the previous year, is attributed to factors such as extensive vaccination campaigns, the emergence of less severe variants, and changing immune responses. The inclusion of comprehensive WHO recommendations emphasizes the ongoing importance of preventive measures. The evolving scenario also highlights the need for continued vigilance, international collaboration, and public health initiatives to minimize the impact of the virus. The advent of JN.1 serves as a reminder of the virus's adaptability and the significance of remaining in advance of emerging variants as the globe struggles with COVID-19's unexpected nature.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975306489240628053226
2024-08-06
2025-10-03

  • From This Site

    /content/journals/covid/10.2174/0126667975306489240628053226
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. LauxmannMA SantucciNE Autrán-GómezAM The SARSCoV-2 coronavirus and the COVID-19 outbreak.Int Braz J Urol20204646)(161810.1590/s1677‑5538.ibju.2020.s101 32549071
     [Google Scholar]
  2. BhargabBD DashB NewarA Coronavirus disease 2019: A comprehensive review on recent clinical updates and management tools for pharmacistsJ pharm biosci202190121
     [Google Scholar]
  3. COVID-19 facilities in States & Union Territories Arogya Setu App.Available from: https://www.mohfw.gov.in/ [Accessed on 29 December 2023].
  4. World Health OrganizationCoronavirus disease 2019 (COVID-19): situation report.Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf
  5. World Health Organization (WHO)Available from: https://www.mygov.in/corona-data/covid19-statewise-status/
  6. COVID-19 state wise statusAvailable from: https://www.who.int/emergencies/surveillance
  7. PRS Legislative ResearchAvailable from: https://prsindia.org/policy/monthly-policy-review/december-2023 [Accessed on 29 December 2023].
  8. Reserve Bank of IndiaAvailable from: https://www.rbi.org.in/SCRIPTs/PublicationsView.aspx?id=21035 [Accessed on 29 December 2023].
  9. The ConversationAvailable from: https://theconversation.com/why-are-covid-cases-in-india-decreasing-despite-the-low-doublevaccination-rate-171736 [Accessed on 29 December 2023].
  10. India TodayAvailable from: https://www.indiatoday.in/business/story/explained-how-lower-demand-impacts-india-s-covid-hit-economy-1804054-2021-05-18 [Accessed on 29 December 2023].
  11. AudiA. AlIbrahimM. KaddouraM. HijaziG. YassineH.M. ZaraketH. Seasonality of respiratory viral infections: will COVID-19 follow suit?Front. Public Health2020856718410.3389/fpubh.2020.567184 33042956
     [Google Scholar]
  12. Romero StarkeK. MauerR. KarskensE. The effect of ambient environmental conditions on COVID-19 mortality: A systematic review.Int. J. Environ. Res. Public Health202118186665
     [Google Scholar]
  13. D’AmicoF. MarmiereM. RighettiB. COVID-19 seasonality in temperate countries.Environ. Res.202220611261410.1016/j.envres.2021.112614 34953888
     [Google Scholar]
  14. LiuX. HuangJ. LiC. The role of seasonality in the spread of COVID-19 pandemic.Environ. Res.2021195110874
     [Google Scholar]
  15. The health siteAvailable from: https://www.thehealthsite.com/news/jn-1-variant-to-delta-how-covid-19-virus-mutated-since-its-first-detection-in-china-wuhan-in-2019-1054286/ [Accessed on 29 December 2023].
  16. HUBAvailable from: https://hub.jhu.edu/2024/01/12/jn1-dominant-variant-covid-surge/ [Accessed on 29 December 2023].
  17. LooiM.K. Covid-19: WHO adds JN.1 as new variant of interest.BMJ20233832975
     [Google Scholar]
  18. Hindustan timesAvailable from: https://www.hindustantimes.com/india-news/how-dangerous-is-jn1-covid-variant-101702911772781.html [Accessed on 29 December 2023].
  19. Business StandardAvailable from: https://www.business-standard.com/india-news/covid-19-update-in-biggest-single-day-spike-india-registers-628-cases-123122500205_1.html [Accessed on 29 December 2023].
  20. IzzoR. PacellaD. TrimarcoV. Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: A longitudinal cohort study.EClinicalMedicine20236610234510.1016/j.eclinm.2023.102345 38143804
     [Google Scholar]
  21. TrimarcoV. IzzoR. PacellaD. Incidence of new-onset hypertension before, during, and after the COVID-19 pandemic: a 7-year longitudinal cohort study in a large population.BMC Med.2024221127
     [Google Scholar]
  22. ChaudhryD. KhandelwalS. BahadurC. Prevalence of long COVID symptoms in Haryana, India: A cross-sectional follow-up study.The Lancet Regional Health Southeast Asia2024125
     [Google Scholar]
  23. ParottoM. GyöngyösiM. HoweK. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations.The Lancet Resp. Med.2023118739754
     [Google Scholar]
  24. HossainM.M. DasJ. RahmanF. Living with “long COVID”: A systematic review and meta-synthesis of qualitative evidence.PloS one2023182e0281884
     [Google Scholar]
  25. ArjunM.C. SinghA.K. PalD. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.PLoS One20221712e0278825
     [Google Scholar]
  26. Rodriguez-MoralesA.J. Lopez-EcheverriM.C. Perez-RagaM.F. The global challenges of the long COVID-19 in adults and children.Travel Med. Infect. Dis.20235410260610.1016/j.tmaid.2023.102606 37295581
     [Google Scholar]
  27. BhattacharyaM. ChatterjeeS. SaxenaS. NandiS.S. LeeS.S. ChakrabortyC. Current landscape of long COVID clinical trials.Int. Immunopharmacol.202413211193010.1016/j.intimp.2024.111930
     [Google Scholar]
/content/journals/covid/10.2174/0126667975306489240628053226
Loading
Navigating the Waves: A Comprehensive Analysis of India's COVID-19 Journey from 2019 to the Arrival of JN.1 Subvariant in 2023
Coronaviruses 6, E26667975306489 (2025); https://doi.org/10.2174/0126667975306489240628053226
/content/journals/covid/10.2174/0126667975306489240628053226
/content/journals/covid/10.2174/0126667975306489240628053226
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): COVID-19; JN.1 subvariant; respiratory droplets; SARS-CoV-2; surveillance; vaccination

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test